Pharsight

AMGEN PATENTS FACING OPPOSITIONS

Top patents of AMGEN facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP2962690B1 16 Jan, 2019 (+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions Thereof NA 15
EP3395339B8 11 Dec, 2019 Rapid Dissolution Formulation Of A Cinacalcet Hcl Sep, 2024 11
EP3395340B8 11 Dec, 2019 Rapid Dissolution Formulation Of Cinacalcet Hcl Sep, 2024 9
EP2780375B1 11 Sep, 2019 Binding Molecules For Bcma And Cd3 NA 9
EP3260117B8 27 Nov, 2019 Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound Sep, 2024 8
EP3578175B1 30 Nov, 2022 Rapid Dissolution Formulation Of A Calcium Receptor-Active Compound Sep, 2024 7
EP2780374B1 21 Aug, 2019 Binding Molecules For Bcma And Cd3 Nov, 2032 7
EP3395338B1 01 May, 2019 Rapid Dissolution Formulation Of Cinacalcet Hcl Sep, 2024 7
EP3227454B1 29 Jan, 2020 Process For Manipulating The Level Of Glycan Content Of A Glycoprotein NA 5
EP3246017B1 24 Mar, 2021 Stable Liquid Formulation Of Amg 416 Hcl (Etelcalcetide) Jun, 2034 4
EP2382228B1 26 Aug, 2020 Compositions And Methods Of Treating Inflammatory And Autoimmune Diseases Jan, 2030 4
EP3681483B1 18 May, 2022 Process For Lyophilized Pharmaceutical Formulation Of A Therapeutic Protein Sep, 2038 3
EP2797581B1 06 May, 2020 Formulations Of (+)-2-[1-(3-Ethoxy-4-Methoxy-Phenyl)-2-Methanesulfonyl-Ethyl]-4-Acetyl Aminoisoindoline-1,3-Dione Dec, 2032 3
EP2637670B2 13 Mar, 2024 Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains NA 2
EP3666797B1 17 May, 2023 Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9) Aug, 2028 2
EP3658203B1 31 Aug, 2022 Drug Delivery Device With Gear Module And Related Method Of Assembly Jul, 2038 2
EP3228315B1 25 Nov, 2020 Prevention Of Adverse Effects Caused By Cd3 Specific Binding Domains Oct, 2031 2
EP2445924B2 13 Dec, 2023 Capture Purification Processes For Proteins Expressed In A Non-Mammalian System NA 1
EP2301961B9 13 Dec, 2023 Sclerostin Epitopes NA 1
EP3334747B1 27 Sep, 2023 Charged Depth Filtration Of Antigen-Binding Proteins NA 1
EP3434760B1 26 Apr, 2023 Methods For Increasing Mannose Content Of Recombinant Proteins NA 1
EP2651400B2 18 Jan, 2023 Controlled Release Oral Dosage Forms Of Poorly Soluble Drugs And Uses Thereof NA 1
EP3464277B1 28 Dec, 2022 Pegylated Carfilzomib Compounds May, 2037 1
EP2970484B2 21 Sep, 2022 Heterodimeric Bispecific Antibodies NA 1
EP3026109B1 09 Mar, 2022 Improved Production Of Glycoproteins Using Manganese NA 1
EP3521440B1 09 Feb, 2022 Methods For Harvesting Mammalian Cell Cultures NA 1
EP2969099B2 22 Dec, 2021 Removal Of Leaked Affinity Purification Ligand NA 1
EP3411402B1 22 Dec, 2021 Bcma And Cd3 Bispecific T Cell Engaging Antibody Constructs NA 1
EP3381942B1 14 Apr, 2021 A Method For Treating Melanoma Using A Herpes Simplex Virus And An Immune Checkpoint Inhibitor Aug, 2033 1
EP3320902B1 17 Feb, 2021 Methods For Treating Diseases Using Isoindoline Compounds Mar, 2032 1
EP3085386B1 24 Jun, 2020 Method For Inhibiting Bone Resorption Sep, 2028 1
EP2641917B1 06 May, 2020 Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9) Aug, 2028 1
EP3412687B1 18 Mar, 2020 Methods For Treating Dlbcl NA 1
EP3126373B1 04 Mar, 2020 Method For Preparing Amg 416 NA 1
EP2837680B1 26 Feb, 2020 Mammalian Cell Culture NA 1
EP2970123B1 14 Aug, 2019 Salt Of Omecamtiv Mecarbil And Process For Preparing Salt NA 1
EP3152317B1 02 Jan, 2019 Methods For Harvesting Mammalian Cell Cultures NA 1
EP3149480B1 26 Dec, 2018 Risk-Stratification Of B-Precursor Acute Lymphoblastic Leukemia Patients NA 1
EP2445923B1 05 Sep, 2018 Refolding Proteins Using A Chemically Controlled Redox State NA 1
EP3018145B1 04 Apr, 2018 Means And Methods For Treating Dlbcl NA 1
EP1461442B1 06 Sep, 2017 Transgenic Animals Bearing Human Ig Lambda Light Chain Genes NA 1
EP2319301B1 06 Sep, 2017 Transgenic Animals Bearing Human Ig Lambda Light Chain Genes NA 1
EP3013318B1 19 Apr, 2017 Stable Liquid Formulation Of Amg 416 (Velcalcetide) NA 1